Zimmer Biomet and RevelAi Health announced a multi-year co-marketing agreement for generative AI-powered value-based care and health equity solutions, according to a company press release.
“Leveraging generative AI to streamline clinical care workflows while addressing sociodemographic disparities is a unique opportunity to drive equitable value-based
outcomes,” Christian A. Péan, MD, MS, CEO of RevelAi Health and orthopedic trauma surgeon at Duke University School of Medicine, said in the release. “Our AI-enabled asynchronous care model delivers personalized, timely and